Evidence map›Paper›PMID 20055706›Full record

ReviewAnnual review of pharmacology and toxicology2010

Metabotropic glutamate receptors: physiology, pharmacology, and disease.

Colleen M Niswender, P Jeffrey Conn

Open access · greenAbstract readReview
In one paragraph

Review in Annual review of pharmacology and toxicology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 965 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
965citing papers in PubMed, 3 pooled it
39.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

965 citing papers in PubMed, 3 syntheses or guidelines pooled it, 1,809 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Molecular pharmacology of mGluMolecular pharmacology · 2026
    Article
  19. Article
  20. Article

905 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Colleen M NiswenderDepartment of Pharmacology, Vanderbilt University, Nashville, Tennessee 37212, USA. colleen.niswender@vanderbilt.edu
P Jeffrey Conn
Vanderbilt University · US

Funding

The Vanderbilt Specialized Chemistry Center for Accelerated Probe DevelopmentU54MH084659 · NIMH · VANDERBILT UNIVERSITY · PI LINDSLEY, CRAIG · 2008 to 2013
$24.1M
REGULATION OF SIGNALING BY MGLUR5R01MH062646 · NIMH · VANDERBILT UNIVERSITY · PI P Jeffrey Conn, COLLEEN M NISWENDER · 2001 to 2026
$10.9M
FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTOR SUBTYPESR01NS031373 · NINDS · VANDERBILT UNIVERSITY · PI CONN, P JEFFREY · 1993 to 2025
$6.2M
Partial Antagonists of mGluR5 for Treatment of Cocaine AddictionR01DA023947 · NIDA · VANDERBILT UNIVERSITY · PI LINDSLEY, CRAIG · 2008 to 2012
$2.1M
Modulators of Metabotropic Glutamate Receptor Subtype 2 for Cocaine DependenceR01DA023926 · NIDA · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI COSFORD, NICHOLAS DAVID · 2007 to 2009
$1.4M
Functional effects of mGluR potentiators in the CNSR01MH074953 · NIMH · VANDERBILT UNIVERSITY · PI CONN, P JEFFREY · 2006 to 2010
$1.4M
NIDA NIH HHS R01 DA023926NIDA NIH HHS R01 DA023947NIMH NIH HHS R01 MH062646NIMH NIH HHS R01 MH074953NIMH NIH HHS U54 MH084659NINDS NIH HHS R01 NS031373
6 · The paper itself

Abstract

The metabotropic glutamate receptors (mGluRs) are family C G-protein-coupled receptors that participate in the modulation of synaptic transmission and neuronal excitability throughout the central nervous system. The mGluRs bind glutamate within a large extracellular domain and transmit signals through the receptor protein to intracellular signaling partners. A great deal of progress has been made in determining the mechanisms by which mGluRs are activated, proteins with which they interact, and orthosteric and allosteric ligands that can modulate receptor activity. The widespread expression of mGluRs makes these receptors particularly attractive drug targets, and recent studies continue to validate the therapeutic utility of mGluR ligands in neurological and psychiatric disorders such as Alzheimer's disease, Parkinson's disease, anxiety, depression, and schizophrenia.

Indexed as

Allosteric RegulationAlternative SplicingAnimalsHumansProtein Structure, TertiaryReceptors, Metabotropic GlutamateSignal TransductionReceptors, Metabotropic Glutamate

Identifiers

PMID20055706
PMCPMC2904507
OpenAlexW2120307371

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.